Unlearn, which develops digital twins for clinical trials, received $ 50 million investment

It is a startup that develops digital twins for use in the field of healthcare. Unlearnannounced that it received a new investment. According to the information provided by Unlearn, the startup is in the C series investment round. 50 million dollars received investment.

Unlearn’s $50 million Series C investment round, Altimeter Capital took place under his leadership. Apart from Altimeter Capital, the investment tour was also attended by investors among the company’s existing investors. Radical Ventures, Wittington Ventures, Mubadala Capital, Epic Ventures ve Necessary Venture Capital also participated.

With the new investment of 50 million dollars, the total investment received by the Unlearn initiative to date is 135 million dollars reached. According to the information provided by Unlearn, the investment will be used to carry out R&D studies and expand the team.

in 2017 Charles Fisher Founded in San Francisco by Unlearn, it develops digital twins of people who will participate in clinical trials using machine learning and artificial intelligence. These digital twins can give researchers detailed insight into participants’ health outcomes.

The main goal of the Unlearn initiative is to further develop artificial intelligence and digital twin technologies, eliminating trial and error in the field of medicine and achieving healthier results. Unlearn is working with pharmaceutical, biotech companies and academic researchers to create digital twins for each patient in a clinical trial. TwinRCT With its solution, it enables clinical trials to be carried out much more efficiently.

Let us also share that digital twin companies focusing on healthcare appear with new investments every day. Last December, we informed you that Twin Health, which develops digital twins in the field of healthcare, received an investment of 50 million dollars. we had transferred.